Improving HIV/AIDS disease surveillance in low-income countries

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda.

The Journal of antimicrobial chemotherapy·2014

Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adults.

Antimicrobial agents and chemotherapy·2010

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.

Lancet (London, England)·2010

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.

HIV medicine·2010

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

Lancet (London, England)·2009

Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2008

Long-term effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and resistance-associated mutations.

AIDS (London, England)·2026

Comparing carbon emissions from oral tenofovir disoproxil fumarate/emtricitabine for preexposure prophylaxis and long-acting injectables for HIV prevention.

AIDS (London, England)·2026

The additive value of coronary calcium in identifying cardiovascular risk in ageing people with HIV.

AIDS (London, England)·2026

Same-day initiation of tenofovir alafenamide-based pre-exposure prophylaxis with drug-level feedback for transgender women in Uganda.

AIDS (London, England)·2026

Viral suppression in models of care for improving engagement of antiretroviral therapy in postpartum women living with HIV.

AIDS (London, England)·2026

Clusters and outbreaks contribute disproportionately to future HIV transmission in the United States.

AIDS (London, England)·2026

Mapping Spatio-Temporal Hotspots of Dengue Transmission in Tasikmalaya, Indonesia.

Journal of vector borne diseases·2026

Medication errors in home care settings: a 13-year retrospective cohort study in the Ramathibodi Poison Center.

Clinical toxicology (Philadelphia, Pa.)·2026

Transition Dynamics of County Obstetric Service Absence: Population Exposure and Status Changes in the United States, 2015-2023.

Health services research·2026

Mapping nationally adopted targets for antimicrobial consumption and stewardship indicators in the human health domain, 25 European Union/European Economic Area countries, 2025.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2026

Evaluation of Nebulized Tranexamic Acid for Acute Secondary Posttonsillectomy Hemorrhage.

OTO open·2026

Epidemiological trends in HIV infection among female sex workers in Cabo Verde, 2013-2023: evidence from three integrated bio-behavioural surveys.

The Pan African medical journal·2026

Related Experiment Videos

Improving HIV/AIDS disease surveillance in low-income countries

Related Concept Videos

Phenotypic and genotypic analyses to guide selection of reverse transcriptase inhibitors in second-line HIV therapy following extended virological failure in Uganda.

Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adults.

Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort.

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.

Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial.

Management of HIV-infected patients with MDR- and XDR-TB in resource-limited settings.

Long-term effectiveness of bictegravir/emtricitabine/tenofovir alafenamide in people with HIV and resistance-associated mutations.

Comparing carbon emissions from oral tenofovir disoproxil fumarate/emtricitabine for preexposure prophylaxis and long-acting injectables for HIV prevention.

The additive value of coronary calcium in identifying cardiovascular risk in ageing people with HIV.

Same-day initiation of tenofovir alafenamide-based pre-exposure prophylaxis with drug-level feedback for transgender women in Uganda.

Viral suppression in models of care for improving engagement of antiretroviral therapy in postpartum women living with HIV.

Clusters and outbreaks contribute disproportionately to future HIV transmission in the United States.

Mapping Spatio-Temporal Hotspots of Dengue Transmission in Tasikmalaya, Indonesia.

Medication errors in home care settings: a 13-year retrospective cohort study in the Ramathibodi Poison Center.

Transition Dynamics of County Obstetric Service Absence: Population Exposure and Status Changes in the United States, 2015-2023.

Mapping nationally adopted targets for antimicrobial consumption and stewardship indicators in the human health domain, 25 European Union/European Economic Area countries, 2025.

Evaluation of Nebulized Tranexamic Acid for Acute Secondary Posttonsillectomy Hemorrhage.

Epidemiological trends in HIV infection among female sex workers in Cabo Verde, 2013-2023: evidence from three integrated bio-behavioural surveys.

Related Experiment Videos

Improving HIV/AIDS disease surveillance in low-income countries

Related Concept Videos

Related Articles